Materials and methods for protecting against neuromas

US9629997B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9629997-B2
Application numberUS-201314036405-A
CountryUS
Kind codeB2
Filing dateSep 25, 2013
Priority dateSep 25, 2012
Publication dateApr 25, 2017
Grant dateApr 25, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of, isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.

First claim

Opening claim text (preview).

We claim: 1. A sterile device for protecting against a neuroma forming at a stump of a transected nerve, wherein the device comprises: a body having an open proximal end and, integrally formed with the body, a closed distal end wherein the body of the device is less than 100 mm in diameter and less than 500 mm in length; wherein the body, including the closed distal end, defines an internal chamber, without openings other than at the proximal end, thereby inhibiting axonal escape from the device when the device is implanted on the nerve stump by inserting the nerve stump through the opening in the proximal end; and one or more separators within the internal chamber that divide the internal chamber thereby creating a plurality of separate volumes into which regenerating axons grow such that one or more regenerating axons are physically separated from one or more other regenerating axons; and wherein the device comprises a biomaterial that remodels into a tissue cushion after implantation. 2. The device according to claim 1 , wherein the device comprises a biomaterial selected from the group consisting of: high density polyethylene (HDPE), polyethylene glycol (PEG) hydrogel, and purified proteins from human or sources. 3. The device according to claim 1 , wherein the device comprises a biomaterial selected from the group consisting of small intestine submucosa (SIS), amnion, dermis, collagen and decellularized fascia. 4. The device according to claim 1 , wherein the body is cylindrical in shape. 5. A method for protecting against neuromas comprising: inserting and securing a nerve stump into a device of claim 1 .

Assignees

Inventors

Classifications

  • A61L31/04Primary

    Macromolecular materials · CPC title

  • A61N1/0558Primary

    Anchoring or fixation means therefor · CPC title

  • for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title

  • for nerve reconstruction · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9629997B2 cover?
The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of, isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of th…
Who is the assignee on this patent?
Axogen Inc, Axogen Corp
What technology area does this patent fall under?
Primary CPC classification A61L31/04. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).